AU2004244850B2 - Processes for making caralluma extracts and uses - Google Patents

Processes for making caralluma extracts and uses Download PDF

Info

Publication number
AU2004244850B2
AU2004244850B2 AU2004244850A AU2004244850A AU2004244850B2 AU 2004244850 B2 AU2004244850 B2 AU 2004244850B2 AU 2004244850 A AU2004244850 A AU 2004244850A AU 2004244850 A AU2004244850 A AU 2004244850A AU 2004244850 B2 AU2004244850 B2 AU 2004244850B2
Authority
AU
Australia
Prior art keywords
extract
composition
process according
caralluma
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2004244850A
Other languages
English (en)
Other versions
AU2004244850A1 (en
AU2004244850A2 (en
Inventor
Kamala Rajendran
Ramaswamy Rajendran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2004244850A1 publication Critical patent/AU2004244850A1/en
Publication of AU2004244850A2 publication Critical patent/AU2004244850A2/en
Priority to AU2008255233A priority Critical patent/AU2008255233B2/en
Application granted granted Critical
Publication of AU2004244850B2 publication Critical patent/AU2004244850B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
AU2004244850A 2003-06-04 2004-05-31 Processes for making caralluma extracts and uses Expired AU2004244850B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008255233A AU2008255233B2 (en) 2003-06-04 2008-12-12 Processes for making caralluma extracts and uses

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN451/MAS/2003 2003-06-04
IN451CH2003 2003-06-04
PCT/IN2004/000150 WO2004108148A1 (en) 2003-06-04 2004-05-31 Processes for making caralluma extracts and uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008255233A Division AU2008255233B2 (en) 2003-06-04 2008-12-12 Processes for making caralluma extracts and uses

Publications (3)

Publication Number Publication Date
AU2004244850A1 AU2004244850A1 (en) 2004-12-16
AU2004244850A2 AU2004244850A2 (en) 2004-12-16
AU2004244850B2 true AU2004244850B2 (en) 2009-01-08

Family

ID=36011983

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2004244850A Expired AU2004244850B2 (en) 2003-06-04 2004-05-31 Processes for making caralluma extracts and uses
AU2008255233A Expired AU2008255233B2 (en) 2003-06-04 2008-12-12 Processes for making caralluma extracts and uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008255233A Expired AU2008255233B2 (en) 2003-06-04 2008-12-12 Processes for making caralluma extracts and uses

Country Status (12)

Country Link
US (2) US7060308B2 (enExample)
EP (1) EP1644013A1 (enExample)
JP (2) JP5260873B2 (enExample)
KR (2) KR20060034229A (enExample)
CN (1) CN1798566B (enExample)
AU (2) AU2004244850B2 (enExample)
BR (1) BRPI0411400A (enExample)
CA (1) CA2527702C (enExample)
CO (1) CO5660269A2 (enExample)
NZ (2) NZ543995A (enExample)
WO (1) WO2004108148A1 (enExample)
ZA (1) ZA200509780B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083795A1 (en) * 2004-10-19 2006-04-20 Lima Shatkina Meal replacement products having appetite suppressing qualities
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060159773A1 (en) * 2005-01-20 2006-07-20 Stephen Holt Herbal compositions containing hoodia
WO2007022141A1 (en) * 2005-08-17 2007-02-22 Charles Tadlock Delivery system for appetite suppressant
CN101505771A (zh) * 2006-08-17 2009-08-12 荷兰联合利华有限公司 含有甾体糖苷的hoodia植物萃取物的制造方法
WO2008107910A2 (en) * 2007-03-05 2008-09-12 Ramaswamy Rajendran Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same
ZA201000727B (en) * 2009-01-30 2010-11-24 Vishwas Sudhu Ghare An improved process for the preparation of caralluma extract and a formulation prepared thereof
US20130122146A1 (en) * 2011-11-16 2013-05-16 Decas Botanical Synergies, Llc Process for Spray Drying Botanical Food
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
TWI687223B (zh) 2013-04-30 2020-03-11 日商日本臟器製藥股份有限公司 萃取物及含有該萃取物的製劑
EP2810565A1 (en) * 2013-06-03 2014-12-10 Dupont Nutrition Biosciences ApS Antioxidant composition
CN103969393A (zh) * 2014-04-25 2014-08-06 上海相宜本草化妆品股份有限公司 用于化妆品中糖苷类中草药化合物含量测试的前处理方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960839A (en) * 1973-02-09 1976-06-01 Escuela Politecnica Nacional Process for recovering and isolating solasodine and glycosides thereof
US5270457A (en) * 1992-06-12 1993-12-14 University Of Manitoba Cardiac steriod glycosides
ATE502041T1 (de) 1997-04-15 2011-04-15 Csir Nicht-therapeutische methode zur appetitunterdrückung
EP0931550B1 (en) * 1998-01-26 2004-09-22 National Research Development Corporation, a Government of India Undertaking A process for the preparation of a spermicidal agent
US6703051B1 (en) 1998-10-13 2004-03-09 Solae, Llc Process for separating and recovering protein and isoflavones from a plant material
US6124442A (en) * 1999-03-24 2000-09-26 Zhou; James H. Process for extracting triterpene glycosides from botanical sources
US6224906B1 (en) * 1999-08-31 2001-05-01 Natreon Inc. St. John's wort composition
US6635758B2 (en) * 2000-09-25 2003-10-21 Industrial Technology Research Institute Process for extracting glycoside using an aqueous two-phase system
EP1994837A3 (en) * 2001-11-16 2009-11-11 Nestec S.A. Plant derived or derivable material with appetite suppressant activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Ahmad V et al. J Nat Prod, 1995. 50(6): 426-428 *
Ramesh M et al. J Ethnopharmacol, 1999.68(1-3): 349-52 *
Rizwani GH et al. J Fac Gazi Univ. 11(1): 43-53 *
Usmanghani et al. Poisonous plants; third International symposium. Iowa State university press, 1992. Pp314-26 *

Also Published As

Publication number Publication date
US7060308B2 (en) 2006-06-13
CN1798566B (zh) 2014-03-12
AU2004244850A1 (en) 2004-12-16
NZ543995A (en) 2009-02-28
NZ573614A (en) 2011-02-25
KR20060034229A (ko) 2006-04-21
JP2013067638A (ja) 2013-04-18
JP2006526615A (ja) 2006-11-24
CA2527702C (en) 2016-03-08
WO2004108148A1 (en) 2004-12-16
KR20070114833A (ko) 2007-12-04
AU2008255233B2 (en) 2012-01-12
CA2527702A1 (en) 2004-12-16
JP5260873B2 (ja) 2013-08-14
US7390516B2 (en) 2008-06-24
US20040247702A1 (en) 2004-12-09
BRPI0411400A (pt) 2006-07-25
ZA200509780B (en) 2006-09-27
EP1644013A1 (en) 2006-04-12
KR100993487B1 (ko) 2010-11-10
CN1798566A (zh) 2006-07-05
US20050163871A1 (en) 2005-07-28
AU2008255233A1 (en) 2009-01-22
AU2004244850A2 (en) 2004-12-16
CO5660269A2 (es) 2006-07-31

Similar Documents

Publication Publication Date Title
AU2008255233B2 (en) Processes for making caralluma extracts and uses
US7078063B2 (en) Water soluble extract from plant of Solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
JP2006526615A5 (enExample)
CN103040882B (zh) 紫果西番莲茎及叶提取物及其药物组合物与抗抑郁作用
CA2980231C (en) Pharmaceutical composition containing silybin
CN108524668A (zh) 一种对药物性肝损伤具有修复和治疗作用的枸杞提取物的制备方法
CN107412393B (zh) 一种黄皮叶多酚提取物的制备方法及其应用
CN111920799B (zh) 一种苦乐果有效成分组合物及其制备方法和应用
KR102698224B1 (ko) 생잎을 이용한 돌외잎차의 제조방법 및 이에 따라 제조된 돌외잎차를 이용한 돌외잎차 추출물의 제조방법
MXPA05013031A (en) Processes for making caralluma extracts and uses
HK1197196A1 (en) Composition of processes for making caralluma extracts
Singh et al. Effect of ethanolic extract of Cestrum nocturnum leaves on blood glucose level of streptozotocin-induced diabetic albino Wistar rats
US8247547B2 (en) Process for the preparation of Caralluma extract and a formulation prepared thereof
CN103845343B (zh) 山核桃甾醇提取物在制备消炎物品中的应用
CN121015632A (zh) 一种具有降血糖功能的茶叶提取物及其制备方法
KR20240097072A (ko) 천연결합제를 첨가한 다이어트용 식품 제조법

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 21 MAR 2006

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired